Introduction
In the network of modern neuroscience, there's a fascinating new discovery called Transcranial Magnetic Stimulation (TMS) that has sparked considerable interest. It is a gentle, non-invasive yet powerful tool that taps into the brain's natural rhythms using magnetic pulses, offering new hope for those grappling with conditions like depression, anxiety, and more recently, Post-Traumatic Stress Disorder (PTSD).1 PTSD, a complex condition stemming from traumatic experiences, can cast a long shadow over one's life, disrupting everyday functioning and overall well-being.2 However, the emergence of TMS presents a promising avenue for relief, shining a light on innovative approaches to mental health treatment. This article aims to provide a clearer picture of what TMS is and how it has the potential to transform the lives of those affected by PTSD.
What is transcranial magnetic stimulation?
Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation technique that is increasingly being used as a therapeutic tool. It involves using magnetic fields to stimulate nerve cells in the brain. A device containing an electromagnetic coil is simply placed near the head. When the coil is turned on, it painlessly delivers magnetic pulses that pass through the skull and generate electric currents that activate nearby brain cells.1
TMS can excite or inhibit functioning in the specific brain region being targeted, depending on the stimulation settings used. Single magnetic pulses can temporarily enhance or disrupt cognitive processing in that area. When given repetitively as a series of pulses (repetitive TMS or rTMS), it can increase or decrease brain excitability beyond the stimulation period itself.3 Multiple TMS sessions over consecutive days have shown accumulation effects that can still influence functioning weeks later. It is a safe way to modulate human brain activity purposefully.4
The most common use of TMS is as a depression treatment, typically using high-frequency rTMS targeting the frontal lobe. However, it shows promise for other conditions like anxiety, PTSD, Parkinson’s disease and chronic pain.5 Proposed mechanisms relate to normalizing underactive brain networks implicated in each disorder. The magnetic fields pass painlessly through the scalp to influence electric signaling between neurons. TMS provides a unique ability to selectively target and rebalance dysfunction in brain regions that mediate neuropsychiatric illness.3
Understanding PTSD
Posttraumatic stress disorder (PTSD) is a psychiatric condition that can occur after exposure to a traumatic event. Trauma that can lead to PTSD includes experiences like war combat, sexual assault, natural disasters, violent crime victimization, and serious accidents. Hallmark PTSD symptoms include re-experiencing the trauma through intrusive memories, nightmares, or flashbacks; avoidance of trauma reminders; negative changes in thoughts and mood like emotional numbing or feeling alienated; and heightened arousal like being easily startled or feeling tense.6
Symptoms must persist for at least a month and cause significant impairment in functioning to meet PTSD diagnostic criteria. According to a study conducted by the World Health Organization (WHO), approximately 3.6% of the world's population experienced PTSD in a given year. Certain factors like childhood adversity and prior mental health issues increase risk. Standard first-line treatments include trauma-focused psychotherapy like prolonged exposure, cognitive processing therapy, along with antidepressants. These aim to process traumatic memories and environmental triggers so they become less disturbing, while also improving mood and anxiety problems.
However many studies have shown that patients fail to respond adequately to existing treatments.9 This highlights the need for novel interventions to address unmet needs. Emerging options like ketamine, MDMA-assisted therapy, and non-invasive brain stimulation techniques are being investigated for more refractory and complex PTSD cases not helped by current gold-standard interventions. Expanding the range of options is critical to improving outcomes, especially for the substantial proportion of patients who see minimal symptom relief from standard therapies.
TMS and PTSD: the promise of a new treatment
Post-Traumatic Stress Disorder (PTSD) has long been a challenging condition to treat effectively. Traditional approaches have typically involved a combination of therapy and medication. While these methods have helped many individuals manage their symptoms, they often fall short in providing complete relief.9 Moreover, some people may experience significant side effects from medications, while others may find therapy alone insufficient to address the complexity of their symptoms.
Traditional treatments for PTSD
Traditionally, PTSD treatment has centered around therapy, particularly cognitive-behavioral therapy (CBT), which aims to help individuals identify and change negative thought patterns and behaviors related to their trauma. Exposure therapy, a type of CBT, involves gradually exposing individuals to reminders of their trauma in a safe environment to help them confront and process their memories. Additionally, medications such as selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly prescribed to alleviate symptoms of anxiety and depression associated with PTSD.
Limitations of current treatments
While therapy and medication can be beneficial for many individuals with PTSD, they have their limitations. Therapy may not always be effective for everyone, and accessing specialized trauma-focused therapy can be challenging. Furthermore, medications may not provide adequate relief for all symptoms and can cause unwanted side effects such as weight gain, sexual dysfunction, or increased risk of suicidal ideation. Effective evidence-based treatment options do exist for PTSD, but many individuals fail to respond well. Various factors, such as improper implementation, lack of therapist training, limited availability of evidence-based trauma-focused treatment providers, and the financial, time, and effort burden on patients required to undergo this treatment modality, likely limit the utility of this treatment option in some clinical settings and for certain patient populations.12
How TMS is different
Transcranial Magnetic Stimulation (TMS) offers a unique approach to treating PTSD that differs from traditional methods in several key ways. Unlike medication, TMS is non-invasive and does not involve introducing drugs into the body, reducing the risk of side effects. Instead, TMS works by delivering focused magnetic pulses to specific areas of the brain involved in regulating mood and emotion. These pulses stimulate neural activity, helping to normalize brain function in individuals with PTSD.1
Moreover, TMS is distinct from traditional therapy in that it directly targets brain circuits implicated in PTSD, rather than relying on verbal or cognitive processes alone. This targeted approach allows for precise modulation of brain activity, potentially offering more rapid and enduring symptom relief compared to therapy alone.13
Research supporting TMS for PTSD
A growing body of research supports the effectiveness of TMS as a treatment for PTSD.14 Several clinical trials have demonstrated significant reductions in PTSD symptoms following TMS treatment, including decreases in intrusive thoughts, avoidance behaviors, and hyperarousal. Furthermore, TMS has been shown to improve overall functioning and quality of life in individuals with PTSD.15
For example, a published study found that individuals with PTSD who received TMS experienced significant reductions in symptoms compared to those who received sham treatment16. These improvements were sustained over time, with many participants maintaining symptom relief even after the conclusion of TMS treatment.
Overall, the evidence suggests that TMS holds promise as a novel and effective treatment for PTSD, offering hope for those who have not responded adequately to traditional approaches. As research in this area continues to advance, TMS may increasingly become a cornerstone of PTSD treatment, helping to alleviate suffering and restore well-being for individuals affected by this debilitating condition.
Contraindications of TMS
- History of epilepsy or seizures: TMS has a small risk of inducing seizures, especially with high-frequency stimulation protocols. Patients with a history of epilepsy or seizure disorder are contraindicated for TMS due to an increased risk.17
- Metallic implants or devices near the stimulation site: The powerful magnetic fields used in TMS can interfere with or potentially dislodge metallic implants like cochlear implants, aneurysm clips, or other devices near the treatment area. These pose a clear contraindication.6
- Ferromagnetic or electromagnetic objects: Objects that can conduct electricity or be affected by magnetic fields, such as jewelry or magnetic strip cards, should be removed from the treatment area to avoid potential risks or interference.6
- Increased risk of head injury: Patients with an increased risk of head injury, such as those with uncontrolled hypertension or at risk for stroke, may not be suitable candidates for TMS due to the potential for adverse events.18
- Pregnancy: While the risks to the fetus are not fully known, TMS is generally contraindicated during pregnancy as a precautionary measure.18
It's important to note that while TMS is generally considered safe, there can be individual variability in how patients respond to the treatment. Proper screening, careful consideration of medical history, and close monitoring during the procedure are essential to minimize risks and ensure the safe application of TMS for PTSD and other conditions.19
Limitations of TMS
While TMS has shown promise as a treatment for various neurological and psychiatric conditions, including PTSD, it is important to recognize its limitations. One significant limitation is the variability in individual responses to TMS. Due to differences in brain anatomy, neural connectivity, and underlying pathologies, patients may experience varying degrees of symptom improvement or even a lack of response to TMS treatment.20
Another limitation is the depth of stimulation. TMS primarily affects the outermost layers of the brain, the cerebral cortex. However, many neuropsychiatric conditions involve deeper brain structures, such as the limbic system and subcortical regions. While TMS can indirectly modulate activity in these deeper regions through cortical connections, its direct impact may be limited.21
TMS therapy also requires multiple treatment sessions, typically administered daily or several times a week, over several weeks. This can be time-consuming and burdensome for some patients, affecting treatment adherence and potentially increasing the overall cost of care.22
Additionally, while TMS is generally well-tolerated, some patients may experience side effects such as headaches, scalp discomfort, or facial muscle twitching during or after the treatment sessions. In rare cases, TMS has been associated with an increased risk of seizures, particularly in patients with pre-existing seizure disorders or those receiving high-frequency stimulation protocols.17
Furthermore, the long-term durability of TMS treatment effects is still under investigation. Some patients may require periodic maintenance sessions or additional interventions to sustain symptom improvement over time.24
It is crucial to weigh the potential benefits of TMS against its limitations and to carefully consider individual patient factors when determining the appropriateness and optimal delivery of this treatment modality.
Summary
Transcranial Magnetic Stimulation (TMS) is a groundbreaking treatment that offers new hope for individuals struggling with conditions like post-traumatic stress disorder (PTSD). Traditionally, PTSD has been treated with therapy and medication, but these methods have their limitations, leaving some people without adequate relief from their symptoms. TMS stands out as a unique, non-invasive therapy that directly targets and influences the brain circuits involved in PTSD, potentially providing faster and more lasting symptom improvement compared to traditional approaches.
Research on TMS for PTSD has shown promising results, with significant reductions in symptoms observed in clinical trials. TMS therapy is generally well-tolerated, but it's important to consider that individuals may respond differently to the treatment, and there is a possibility of side effects like headaches or scalp discomfort. Additionally, certain factors, such as a history of seizures or the presence of metallic implants near the treatment area, should be carefully evaluated before undergoing TMS, as they may pose contraindications.
While TMS holds tremendous promise as a transformative treatment for PTSD, it's crucial to approach its implementation with caution, weighing both its potential benefits and limitations. By carefully considering the risks and benefits and tailoring treatment approaches to each individual, TMS has the potential to offer meaningful relief and improve the lives of those affected by PTSD, paving the way for a brighter future in mental health care.
References
- Hallett M. Transcranial magnetic stimulation: a primer. Neuron. 2007;55(2): 187–199. https://doi.org/10.1016/j.neuron.2007.06.026.
- McFARLANE AC. The long-term costs of traumatic stress: intertwined physical and psychological consequences. World Psychiatry. 2010;9(1): 3–10. https://doi.org/10.1002/j.2051-5545.2010.tb00254.x.
- Chail A, Saini RK, Bhat PS, Srivastava K, Chauhan V. Transcranial magnetic stimulation: A review of its evolution and current applications. Industrial Psychiatry Journal. 2018;27(2): 172–180. https://doi.org/10.4103/ipj.ipj_88_18.
- Valero-Cabré A, Pascual-Leone A, Rushmore RJ. Cumulative sessions of repetitive transcranial magnetic stimulation (Rtms) build up facilitation to subsequent TMS-mediated behavioural disruptions. The European Journal of Neuroscience. 2008;27(3): 765–774. https://doi.org/10.1111/j.1460-9568.2008.06045.x.
- Gershon AA, Dannon PN, Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. The American Journal of Psychiatry. 2003;160(5): 835–845. https://doi.org/10.1176/appi.ajp.160.5.835.
- Watts BV, Schnurr PP, Mayo L, Young-Xu Y, Weeks WB, Friedman MJ. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. The Journal of Clinical Psychiatry. 2013;74(6): e541-550. https://doi.org/10.4088/JCP.12r08225.
- Fonzo GA, Federchenco V, Lara A. Predicting and managing treatment non-response in posttraumatic stress disorder. Current Treatment Options in Psychiatry. 2020;7(2): 70–87. https://doi.org/10.1007/s40501-020-00203-1.
- Lefaucheur JP. Transcranial magnetic stimulation. Handbook of Clinical Neurology [Internet]. 2019;160:559–80. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31277876
- Petrosino NJ, Cosmo C, Berlow YA, Zandvakili A, van ’t Wout-Frank M, Philip NS. Transcranial magnetic stimulation for post-traumatic stress disorder. Therapeutic Advances in Psychopharmacology. 2021;11: 20451253211049921. https://doi.org/10.1177/20451253211049921.
- Edinoff AN, Hegefeld TL, Petersen M, Patterson JC, Yossi C, Slizewski J, et al. Transcranial magnetic stimulation for post-traumatic stress disorder. Frontiers in Psychiatry. 2022;13: 701348. https://doi.org/10.3389/fpsyt.2022.701348.
- Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: A randomized controlled study. Brain Research Bulletin. 2018;140: 334–340. https://doi.org/10.1016/j.brainresbull.2018.06.001.
- Stultz DJ, Osburn S, Burns T, Pawlowska-Wajswol S, Walton R. Transcranial magnetic stimulation (Tms) safety with respect to seizures: a literature review. Neuropsychiatric Disease and Treatment. 2020;16: 2989–3000. https://doi.org/10.2147/NDT.S276635.
- Taylor R, Galvez V, Loo C. Transcranial magnetic stimulation (Tms) safety: a practical guide for psychiatrists. Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists. 2018;26(2): 189–192. https://doi.org/10.1177/1039856217748249.
- Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology. 2009;120(12): 2008–2039. https://doi.org/10.1016/j.clinph.2009.08.016.
- Chew T, Ho KA, Loo CK. Inter- and intra-individual variability in response to transcranial direct current stimulation (Tdcs) at varying current intensities. Brain Stimulation. 2015;8(6): 1130–1137. https://doi.org/10.1016/j.brs.2015.07.031.
- Sliwinska MW, Vitello S, Devlin JT. Transcranial magnetic stimulation for investigating causal brain-behavioral relationships and their time course. Journal of Visualized Experiments: JoVE. 2014;(89): 51735. https://doi.org/10.3791/51735.
- Bulteau S, Laurin A, Volteau C, Dert C, Lagalice L, Schirr-Bonnans S, et al. Cost-utility analysis of curative and maintenance repetitive transcranial magnetic stimulation (Rtms) for treatment-resistant unipolar depression: a randomized controlled trial protocol. Trials. 2020;21: 312. https://doi.org/10.1186/s13063-020-04255-9.
- Mantovani A, Pavlicova M, Avery D, Nahas Z, McDonald WM, Wajdik CD, et al. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (Tms) in treatmnt-resistant depression. Depression and anxiety. 2012;29(10): 883–890. https://doi.org/10.1002/da.21967.

